ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA) ("IPA" or the "Company"), a global leader in AI-powered antibody discovery and ...

ImmunoPrecise Antibodies Ltd., an AI-powered antibody company, has partnered with RIBOPRO, a technology provider specializing ...

When people undergo radiotherapy for cancer, it's not just the tumor that suffers. The radiation causes DNA breaks in healthy ...

Generation Bio (NASDAQ:GBIO – Get Free Report) is anticipated to post its quarterly earnings results before the market opens on Wednesday, March 5th. Analysts expect Generation Bio to post earnings of ...

This approach could transform radiation therapy by allowing higher doses to be used more safely, ultimately improving outcomes for cancer patients.

YolTech Therapeutics reports positive clinical data for YOLT-203, an in vivo gene editing therapy for primary hyperoxaluria type 1: Shanghai, China Wednesday, February 26, 2025, 1 ...

About 60% of all cancer patients in the United States receive radiation therapy as part of their treatment. However, this ...

Tardigrades, microscopic organisms renowned for their extraordinary resistance to radiation, may offer a means to protect ...

Scientists developed a method to protect cancer patients from radiation damage using a protein from tardigrades. When ...

Arbutus Biopharma Corporation (Nasdaq: ABUS) has announced significant changes to its leadership team, naming Lindsay ...

About 60 percent of all cancer patients in the United States receive radiation therapy as part of their treatment.